DATE: May 31, 2017
TIME: 6:00PM PDT, 9:00AM SGT, 12:00PM AEDT
Gain insights into T-cell expansion, viral vector production and scaling production of mesenchymal stem cells (MSCs) through the use of a functionally closed, automated, cell culture process.
Dr. Beltzer (Terumo BCT, CO, U.S.) will present a number of case studies to describe how process development and economic goals were achieved in both industry and academic settings. Results include up to a 500-fold expansion of T-cells in 12 days, 40 percent reduction in cost of goods (COGs) of growing cells for an allogeneic therapy, and automated viral vector production with titers similar to flask-based processes. Particular attention will be directed toward the process changes often needed to meet these goals.
Who may this interest?
• Clinicians, researchers, lab technologists and cell therapy industry professionals
• Cell therapy manufacturing professionals
• Gene and immunotherapy manufacturing professionals
Medical Laboratory Technician7%
Clinical Laboratory Scientist3%
Medical Device Company3%
Life Science Company3%
Contract Research Organization (Cro)2%